LUNERTI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 195
EU - Europa 108
AS - Asia 72
SA - Sud America 18
AF - Africa 14
OC - Oceania 1
Totale 408
Nazione #
US - Stati Uniti d'America 193
IT - Italia 40
SG - Singapore 25
HK - Hong Kong 22
CN - Cina 21
BR - Brasile 17
DE - Germania 15
RU - Federazione Russa 12
CI - Costa d'Avorio 9
FR - Francia 7
AT - Austria 5
FI - Finlandia 5
GB - Regno Unito 5
IE - Irlanda 4
MA - Marocco 4
SE - Svezia 4
NL - Olanda 3
PL - Polonia 3
VN - Vietnam 3
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
MX - Messico 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 408
Città #
Dallas 55
Ashburn 42
Hong Kong 22
Munich 14
Singapore 12
Boardman 10
Abidjan 9
Ancona 6
Chandler 6
New York 6
Macerata 5
The Dalles 5
Dublin 4
Los Angeles 4
Moscow 4
Phoenix 4
São Paulo 4
Xi'an 4
Chicago 3
Hefei 3
Turku 3
Vienna 3
Warsaw 3
Atlanta 2
Concord 2
Denver 2
Des Moines 2
Easley 2
Fairfield 2
Helsinki 2
Houston 2
Milan 2
Ningbo 2
North Bergen 2
Orange 2
Paris 2
Poplar 2
Santa Clara 2
Sassoferrato 2
Seattle 2
Tolentino 2
Wuhan 2
Bari 1
Beijing 1
Blumenau 1
Boa Viagem 1
Boston 1
Buffalo 1
Camaçari 1
Campo Mourão 1
Campos dos Goytacazes 1
Chelyabinsk 1
City of London 1
Columbus 1
Conselheiro Lafaiete 1
Curitiba 1
Elk Grove Village 1
Florence 1
Hangzhou 1
Hanoi 1
Ho Chi Minh City 1
Huizhou 1
Imbituba 1
Jiaxing 1
Johannesburg 1
Lawrence 1
Magé 1
Manchester 1
Montecosaro 1
Montreal 1
Ninh Bình 1
Nuremberg 1
Olomouc 1
Prescot 1
Princeton 1
Querétaro 1
Ribeirão Preto 1
Roubaix 1
Santo Domingo de los Colorados 1
Sarandi 1
Secaucus 1
Simferopol 1
Tallinn 1
Tampa 1
Urbisaglia 1
Varginha 1
Vitória de Santo Antão 1
Washington 1
Zurich 1
Totale 316
Nome #
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 140
New Insights into Hormonal Therapies in Uterine Sarcomas 103
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 94
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma 80
Totale 417
Categoria #
all - tutte 1.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 2 1 2 1
2022/202320 1 3 1 1 1 2 0 2 4 0 5 0
2023/202454 5 2 2 2 5 5 0 0 0 1 0 32
2024/2025148 15 10 19 4 8 5 19 5 25 8 14 16
2025/2026189 31 32 53 36 32 5 0 0 0 0 0 0
Totale 417